Predicting cardiovascular risk in a Chinese primary Sjögren's syndrome population: development and assessment of a

Jincheng Pu1, Jiamin Song1, Shengnan Pan1

  • 1Department of Rheumatology and Immunology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.

Insights

Patients with primary Sjögren's syndrome (pSS) face higher cardiovascular risks. A new nomogram identifies key risk factors like joint pain, dry mouth, and elevated TSH, aiding in early cardiovascular event prediction and treatment guidance.

Area of Science:

  • Rheumatology
  • Cardiology
  • Medical Informatics

Background:

  • Primary Sjögren's syndrome (pSS) patients exhibit increased cardiovascular morbidity compared to the general population.
  • Identifying specific risk factors for cardiovascular events in pSS is crucial for proactive management.

Purpose of the Study:

  • To identify potential risk factors for cardiovascular events in Chinese patients with pSS.
  • To develop and validate a predictive cardiovascular risk nomogram for pSS patients.

Main Methods:

  • Retrospective observational study of 349 pSS patients diagnosed between 2010 and 2022.
  • Utilized Least Absolute Shrinkage and Selection Operator (LASSO) for feature selection.
  • Developed a multivariate logistic regression model, validated using C-index, ROC curves, calibration plots, and decision curve analysis.

Main Results:

  • A nomogram was developed incorporating sex, joint pain, dry mouth, oral ulcers, dental caries, Raynaud's phenomenon, fatigue, diabetes, elevated TSH, and systolic blood pressure.
  • The model demonstrated good discrimination (C-index: 0.824) and calibration (internal validation C-index: 0.8).
  • Decision curve analysis confirmed clinical utility for interventions at a 3% cardiovascular disease probability threshold.

Conclusions:

  • A validated cardiovascular risk nomogram can predict cardiovascular risk in pSS patients.
  • The nomogram, including identified clinical and laboratory factors, can guide further treatment strategies for pSS patients.
Abstract

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
34
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
17
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
9
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
20